Thus, in a therapy-refractory IBD patient with a genetic defect in the XIAP (X-linked inhibitor of apoptosis) gene and in young children with defects of the IL10 pathway, hematopoetic stem cell transplants (HSCT) were curative (68–71). Here, XIAP is linked to inflammatory bowel disease.